Lv5
1026 积分 2024-10-24 加入
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
23天前
已完结
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis
23天前
已完结
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis
23天前
已完结
Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients
30天前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
1个月前
已关闭
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
1个月前
已完结
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
1个月前
已完结
Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease
1个月前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
2个月前
已关闭
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
2个月前
已完结
皖公网安备34019202002308
